Terms: = Gastric cancer AND SMAD3, JV15-2, 4088, ENSG00000166949, P84022, Smad3, MADH3, HsT17436, Smad 3, DKFZp686J10186, HSPC193, DKFZP586N0721, MGC60396 AND Diagnosis
4 results:
1. Identification of miR-143-3p as a diagnostic biomarker in gastric cancer.
Ju Y; Choi GE; Lee MW; Jeong M; Kwon H; Kim DH; Kim J; Jin H; Lee KE; Hyun KY; Jang A
BMC Med Genomics; 2023 Jun; 16(1):135. PubMed ID: 37328880
[TBL] [Abstract] [Full Text] [Related]
2. Downregulation of TRIM33 Promotes Survival and Epithelial-Mesenchymal Transition in gastric cancer.
Wang F; Wang W; Wu X; Tang C; Du F; Lu Z; Zhang Z; Xu H; Cao X; Li PA
Technol Cancer Res Treat; 2022; 21():15330338221114505. PubMed ID: 35929141
[TBL] [Abstract] [Full Text] [Related]
3. LncRNA SNHG3 Promotes Hepatocellular Tumorigenesis by Targeting miR-326.
Zhao Q; Wu C; Wang J; Li X; Fan Y; Gao S; Wang K
Tohoku J Exp Med; 2019 Sep; 249(1):43-56. PubMed ID: 31548493
[TBL] [Abstract] [Full Text] [Related]
4. Gastroscopic biopsy: reliability of histological diagnosis with special reference to the single biopsy.
Johansen A; Sikjaer B
Scand J Gastroenterol; 1975; 10(5):453-8. PubMed ID: 1153940
[TBL] [Abstract] [Full Text] [Related]
